Guides & articlesPage 1 of 2
Written guides covering the parts of compounded therapy a clinician has to get right every time: how a lyophilized vial is reconstituted, how a dose becomes syringe units, what separates a 503A preparation from a 503B batch, and which adverse findings warrant a hold or an escalation.
GLP-1 dosing & titration
Semaglutide and tirzepatide weekly ladders, escalation intervals, missed-dose handling, and converting a tier into syringe units.
503A vs 503B
Patient-specific compounding versus outsourcing-facility batches: oversight, office stock, beyond-use dating, and what to verify.
Reconstitution guide
Diluent selection, aseptic technique, dissolution, labeling, and the concentration arithmetic behind a reconstituted vial.
Sterile technique & handling
A working checklist for preparing injectables outside a cleanroom: surface prep, septum disinfection, device selection, common errors, and sharps disposal.
Side effects & adverse events
Expected versus escalate-now findings on GLP-1 and peptide therapy, dose-hold guidance, injection-site triage, and how to report an event.
Reading insulin syringes
What a syringe unit means, U-100 / U-50 / U-40 calibration, milliliter conversions, and mg vs mcg vs IU.